SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 14.65% in the revenue at Rs. 858.63 millions was reported in the March 2026 quarter as compared to Rs. 748.93 millions during year-ago period.The Net Loss for the quarter ended March 2026 is Rs. -214.35 millions as compared to Net Loss of Rs. -103.28 millions of corresponding quarter ended March 2025 Operating profit Margin for the quarter ended March 2026 further decreased to -220.83% as compared to -98.59% of corresponding quarter ended March 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 858.63 748.93 14.65 3335.98 3457.68 -3.52 3335.98 3457.68 -3.52
Other Income -248.38 -51.14 385.69 74.53 295.81 -74.80 74.53 295.81 -74.80
PBIDT -220.83 -98.59 123.99 129.19 326.07 -60.38 129.19 326.07 -60.38
Interest 4.29 1.32 225.00 26.32 4.10 541.95 26.32 4.10 541.95
PBDT -225.12 -99.91 125.32 102.87 321.97 -68.05 102.87 321.97 -68.05
Depreciation 27.22 18.18 49.72 97.63 69.69 40.09 97.63 69.69 40.09
PBT -252.34 -118.09 113.68 5.24 252.28 -97.92 5.24 252.28 -97.92
TAX -37.99 -14.81 156.52 20.20 80.27 -74.83 20.20 80.27 -74.83
Deferred Tax -39.89 -32.69 22.03 -12.75 21.03 -160.63 -12.75 21.03 -160.63
PAT -214.35 -103.28 107.54 -14.96 172.01 -108.70 -14.96 172.01 -108.70
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) -25.72 -13.16 95.37 3.87 9.43 -58.93 3.87 9.43 -58.93

Albert David Share Price

707.90 -14.05 (-1.95%)
05-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.55
Dr. Reddys Lab 1277.80
Cipla 1400.70
Zydus Lifesciences 1088.90
Lupin 2268.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×